518 related articles for article (PubMed ID: 23376360)
1. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
2. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
3. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
4. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
5. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
6. Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?
Tamada T; Ito K; Yamamoto A; Yasokawa K; Higaki A; Kanki A; Sato T; Tanimoto D; Higashi H
J Magn Reson Imaging; 2013 May; 37(5):1093-9. PubMed ID: 23148032
[TBL] [Abstract][Full Text] [Related]
7. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma.
Ariizumi S; Kitagawa K; Kotera Y; Takahashi Y; Katagiri S; Kuwatsuru R; Yamamoto M
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):575-85. PubMed ID: 21360083
[TBL] [Abstract][Full Text] [Related]
8. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
Eur J Radiol; 2012 Nov; 81(11):3002-9. PubMed ID: 22748558
[TBL] [Abstract][Full Text] [Related]
9. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
10. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
[TBL] [Abstract][Full Text] [Related]
11. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.
Inoue T; Hyodo T; Murakami T; Takayama Y; Nishie A; Higaki A; Korenaga K; Sakamoto A; Osaki Y; Aikata H; Chayama K; Suda T; Takano T; Miyoshi K; Koda M; Numata K; Tanaka H; Iijima H; Ochi H; Hirooka M; Imai Y; Kudo M
Dig Dis; 2013; 31(5-6):472-9. PubMed ID: 24281023
[TBL] [Abstract][Full Text] [Related]
12. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI.
Takeishi K; Yoshizumi T; Itoh S; Yugawa K; Yoshiya S; Toshima T; Harada N; Ikegami T; Nishie A; Mori M
Ann Surg Oncol; 2020 Sep; 27(9):3344-3353. PubMed ID: 32246316
[TBL] [Abstract][Full Text] [Related]
13. Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Akai H; Matsuda I; Kiryu S; Tajima T; Takao H; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
Eur J Radiol; 2012 Nov; 81(11):2973-7. PubMed ID: 22280873
[TBL] [Abstract][Full Text] [Related]
14. Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
Eur J Radiol; 2012 Dec; 81(12):3839-45. PubMed ID: 22884705
[TBL] [Abstract][Full Text] [Related]
15. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
16. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
17. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
18. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
[TBL] [Abstract][Full Text] [Related]
19. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
Golfieri R; Garzillo G; Ascanio S; Renzulli M
Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.
Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H
J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
